The list of treatment options on the Sweet's Syndrome UK blog was last updated on Feb 2017.
Anakinra (Kineret), adalimumab (Humira), rituximab (Rituxan), and sulfapyridine have been used to successfully treat persistent or difficult-to-treat Sweet's syndrome.
Anakinra is now being used more often as a treatment for Sweet's syndrome when other treatments have failed to manage it, and is also used to treat autoinflammation of unknown cause: autoinflammatie.nl/ENG/fold...
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.